These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24748476)

  • 61. Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure.
    Cao F; Maguire ML; McAndrew DJ; Lake HA; Neubauer S; Zervou S; Schneider JE; Lygate CA
    Basic Res Cardiol; 2020 Jan; 115(2):12. PubMed ID: 31925563
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.
    Shizukuda Y; Matoba S; Mian OY; Nguyen T; Hwang PM
    Mol Cell Biochem; 2005 May; 273(1-2):25-32. PubMed ID: 16013437
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes.
    Feridooni T; Hotchkiss A; Remley-Carr S; Saga Y; Pasumarthi KB
    PLoS One; 2011; 6(7):e22801. PubMed ID: 21829519
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.
    Durham KK; Kluck G; Mak KC; Deng YD; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1447-H1457. PubMed ID: 31002281
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
    Matsumura N; Zordoky BN; Robertson IM; Hamza SM; Parajuli N; Soltys CM; Beker DL; Grant MK; Razzoli M; Bartolomucci A; Dyck JRB
    Cardiovasc Res; 2018 Aug; 114(10):1350-1359. PubMed ID: 29566148
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha.
    Janczewski AM; Kadokami T; Lemster B; Frye CS; McTiernan CF; Feldman AM
    Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H960-9. PubMed ID: 12578819
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure.
    Pacher P; Liaudet L; Bai P; Virag L; Mabley JG; Haskó G; Szabó C
    J Pharmacol Exp Ther; 2002 Mar; 300(3):862-7. PubMed ID: 11861791
    [TBL] [Abstract][Full Text] [Related]  

  • 68. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
    Venkatesan B; Prabhu SD; Venkatachalam K; Mummidi S; Valente AJ; Clark RA; Delafontaine P; Chandrasekar B
    Cell Signal; 2010 May; 22(5):809-20. PubMed ID: 20074638
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.
    Otaki Y; Takahashi H; Watanabe T; Funayama A; Netsu S; Honda Y; Narumi T; Kadowaki S; Hasegawa H; Honda S; Arimoto T; Shishido T; Miyamoto T; Kamata H; Nakajima O; Kubota I
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796253
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiac-Specific Overexpression of miR-222 Induces Heart Failure and Inhibits Autophagy in Mice.
    Su M; Chen Z; Wang C; Song L; Zou Y; Zhang L; Hui R; Wang J
    Cell Physiol Biochem; 2016; 39(4):1503-11. PubMed ID: 27614440
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway.
    Liu MH; Lin XL; Guo DM; Zhang Y; Yuan C; Tan TP; Chen YD; Wu SJ; Ye ZF; He J
    Mol Med Rep; 2016 Feb; 13(2):1281-6. PubMed ID: 26675978
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reduction of caspase-8 and -9 cleavage is associated with increased c-FLIP and increased binding of Apaf-1 and Hsp70 after neonatal hypoxic/ischemic injury in mice overexpressing Hsp70.
    Matsumori Y; Northington FJ; Hong SM; Kayama T; Sheldon RA; Vexler ZS; Ferriero DM; Weinstein PR; Liu J
    Stroke; 2006 Feb; 37(2):507-12. PubMed ID: 16397188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.
    Morihara H; Yamamoto T; Oiwa H; Tonegawa K; Tsuchiyama D; Kawakatsu I; Obana M; Maeda M; Mohri T; Obika S; Fujio Y; Nakayama H
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):273-282. PubMed ID: 27811197
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
    Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
    PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tanshinone IIA inhibits cardiomyocyte apoptosis and rescues cardiac function during doxorubicin-induced cardiotoxicity by activating the DAXX/MEK/ERK1/2 pathway.
    Xu L; He D; Wu Y; Shen L; Wang Y; Xu Y
    Phytomedicine; 2022 Dec; 107():154471. PubMed ID: 36182795
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis.
    Zhao Y; Wang W; Qian L
    Cell Stress Chaperones; 2007; 12(1):83-95. PubMed ID: 17441510
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
    Mukhopadhyay P; Rajesh M; Bátkai S; Kashiwaya Y; Haskó G; Liaudet L; Szabó C; Pacher P
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1466-83. PubMed ID: 19286953
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms.
    Wu S; Lan J; Li L; Wang X; Tong M; Fu L; Zhang Y; Xu J; Chen X; Chen H; Li R; Wu Y; Xin J; Yan X; Li H; Xue K; Li X; Zhuo C; Jiang W
    Cell Biol Toxicol; 2023 Feb; 39(1):237-258. PubMed ID: 34713381
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.
    Zhu W; Soonpaa MH; Chen H; Shen W; Payne RM; Liechty EA; Caldwell RL; Shou W; Field LJ
    Circulation; 2009 Jan; 119(1):99-106. PubMed ID: 19103993
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy.
    Toko H; Takahashi H; Kayama Y; Oka T; Minamino T; Okada S; Morimoto S; Zhan DY; Terasaki F; Anderson ME; Inoue M; Yao A; Nagai R; Kitaura Y; Sasaguri T; Komuro I
    Circulation; 2010 Aug; 122(9):891-9. PubMed ID: 20713897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.